A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood
Clinical trial NCT06255340 · COMPLETED
Trial details
- NCT number
- NCT06255340
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-11
- Primary completion
- 2024-08-28
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.